SGFY Insider Trading Activity and SEC Form 4 Filings
SGFY insider trading summary
No open-market insider purchases or sales of Signify Health, Inc. (SGFY) have been reported on SEC Form 4 in the past 12 months.
Latest SGFY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 9, 2022 | Bradford Kyle Armbrester | Chief Executive Officer | Buy | $98K (8,320 @ $11.77) |
| May 9, 2022 | Steve Senneff | Pres. Chief Fin. & Admin. Off. | Buy | $29K (2,500 @ $11.75) |
| May 6, 2022 | Steve Senneff | Pres. Chief Fin. & Admin. Off. | Buy | $126K (10,000 @ $12.55) |
| Nov 22, 2021 | Steve Senneff | Pres. Chief Fin. & Admin. Off. | Buy | $33K (2,500 @ $13.27) |
| Nov 17, 2021 | Steve Senneff | Pres. Chief Fin. & Admin. Off. | Buy | $149K (10,000 @ $14.92) |
| Nov 16, 2021 | Steve Senneff | Pres. Chief Fin. & Admin. Off. | Buy | $153K (10,000 @ $15.32) |
| Feb 16, 2021 | Marc D Rothman | Chief Medical Officer | Buy | $24K (1,000 @ $24.00) |
| Feb 16, 2021 | Adam McAnaney | General Counsel and Secretary | Buy | $334K (13,900 @ $24.00) |
| Feb 16, 2021 | Vivian E. Riefberg | Director | Buy | $334K (13,900 @ $24.00) |
| Feb 16, 2021 | Laurel Douty | EVP, Clinic. Ops, Care Srvces | Buy | $240K (10,000 @ $24.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.